153 related articles for article (PubMed ID: 27346139)
1. Rebound growth of hepatic colorectal metastases after neo-adjuvant chemotherapy: effect on survival after resection.
Lim E; Wiggans MG; Shahtahmassebi G; Aroori S; Bowles MJ; Briggs CD; Stell DA
HPB (Oxford); 2016 Jul; 18(7):586-92. PubMed ID: 27346139
[TBL] [Abstract][Full Text] [Related]
2. Liver resection after chemotherapy and tumour downsizing in patients with initially unresectable colorectal cancer liver metastases.
Devaud N; Kanji ZS; Dhani N; Grant RC; Shoushtari H; Serrano PE; Nanji S; Greig PD; McGilvray I; Moulton CA; Wei A; Gallinger S; Cleary SP
HPB (Oxford); 2014 May; 16(5):475-80. PubMed ID: 23927606
[TBL] [Abstract][Full Text] [Related]
3. The pre-operative rate of growth of colorectal metastases in patients selected for liver resection does not influence post-operative disease-free survival.
Wiggans MG; Shahtahmassebi G; Aroori S; Bowles MJ; Briggs C; Stell DA
Eur J Surg Oncol; 2016 Mar; 42(3):426-32. PubMed ID: 26821736
[TBL] [Abstract][Full Text] [Related]
4. Morphological aspects of the hepatic response to neoadjuvant therapy.
Fernández-Aceñero MJ; Cortés-Guiral D; Muñoz LE; Martínez-Useros J; Pastor-Idoate C
Pathol Res Pract; 2015 Sep; 211(9):665-70. PubMed ID: 26163186
[TBL] [Abstract][Full Text] [Related]
5. Tumour growth after portal vein embolization with pre-procedural chemotherapy for colorectal liver metastases.
Spelt L; Sparrelid E; Isaksson B; Andersson RG; Sturesson C
HPB (Oxford); 2015 Jun; 17(6):529-35. PubMed ID: 25726854
[TBL] [Abstract][Full Text] [Related]
6. Systematic review of systemic adjuvant, neoadjuvant and perioperative chemotherapy for resectable colorectal-liver metastases.
Khoo E; O'Neill S; Brown E; Wigmore SJ; Harrison EM
HPB (Oxford); 2016 Jun; 18(6):485-93. PubMed ID: 27317952
[TBL] [Abstract][Full Text] [Related]
7. From the completion of neoadjuvant chemotherapy to surgery for colorectal cancer liver metastasis: What is the optimal timing?
Chen Q; Mao R; Zhao J; Bi X; Li Z; Huang Z; Zhang Y; Zhou J; Zhao H; Cai J
Cancer Med; 2020 Nov; 9(21):7849-7862. PubMed ID: 32886456
[TBL] [Abstract][Full Text] [Related]
8. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D
BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865
[TBL] [Abstract][Full Text] [Related]
9. ACE Inhibitor Therapy Does Not Influence the Survival Outcomes of Patients with Colorectal Liver Metastases Following Liver Resection.
Sanyal S; Alabraba E; Ibrahim H; Olaru A; Cameron I; Gomez D
J Gastrointest Cancer; 2021 Mar; 52(1):106-112. PubMed ID: 31853827
[TBL] [Abstract][Full Text] [Related]
10. Increased carcinoembryonic antigen (CEA) following neoadjuvant chemotherapy predicts poor prognosis in patients that undergo hepatectomy for liver-only colorectal metastases.
Neofytou K; Giakoustidis A; Neves MC; Morrison D; Giakoustidis D; Khan AZ; Stebbing J; Mudan S
Langenbecks Arch Surg; 2017 Jun; 402(4):599-605. PubMed ID: 27043945
[TBL] [Abstract][Full Text] [Related]
11. Bevacizumab improves survival in patients with synchronous colorectal liver metastases provided the primary tumor is resected first.
Lim C; Doussot A; Osseis M; Esposito F; Salloum C; Calderaro J; Tournigand C; Azoulay D
Clin Transl Oncol; 2018 Oct; 20(10):1274-1279. PubMed ID: 29594943
[TBL] [Abstract][Full Text] [Related]
12. Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases.
Chun YS; Vauthey JN; Boonsirikamchai P; Maru DM; Kopetz S; Palavecino M; Curley SA; Abdalla EK; Kaur H; Charnsangavej C; Loyer EM
JAMA; 2009 Dec; 302(21):2338-44. PubMed ID: 19952320
[TBL] [Abstract][Full Text] [Related]
13. Short- and long-term results of extended left hepatectomy for colorectal metastases.
Wicherts DA; de Haas RJ; Andreani P; Ariche A; Salloum C; Pascal G; Castaing D; Adam R; Azoulay D
HPB (Oxford); 2011 Aug; 13(8):536-43. PubMed ID: 21762296
[TBL] [Abstract][Full Text] [Related]
14. High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome.
Brouquet A; Abdalla EK; Kopetz S; Garrett CR; Overman MJ; Eng C; Andreou A; Loyer EM; Madoff DC; Curley SA; Vauthey JN
J Clin Oncol; 2011 Mar; 29(8):1083-90. PubMed ID: 21263087
[TBL] [Abstract][Full Text] [Related]
15. Clinical risk scores in the current era of neoadjuvant chemotherapy for colorectal liver metastases.
Kumar R; Dennison AR; Robertson V; Jones MJ; Neal CP; Garcea G
ANZ J Surg; 2018 Jan; 88(1-2):E16-E20. PubMed ID: 27621179
[TBL] [Abstract][Full Text] [Related]
16. The impact of neoadjuvant chemotherapy on skeletal muscle depletion and preoperative sarcopenia in patients with resectable colorectal liver metastases.
Eriksson S; Nilsson JH; Strandberg Holka P; Eberhard J; Keussen I; Sturesson C
HPB (Oxford); 2017 Apr; 19(4):331-337. PubMed ID: 28089364
[TBL] [Abstract][Full Text] [Related]
17. A Randomized Phase II Study of Perioperative Chemotherapy Plus Bevacizumab Versus Postoperative Chemotherapy Plus Bevacizumab in Patients With Upfront Resectable Hepatic Colorectal Metastases.
Chun YJ; Kim SG; Lee KW; Cho SH; Kim TW; Baek JY; Park YS; Hong S; Chu CW; Beom SH; Jung M; Shin SJ; Ahn JB
Clin Colorectal Cancer; 2020 Sep; 19(3):e140-e150. PubMed ID: 32402681
[TBL] [Abstract][Full Text] [Related]
18. Detailed liver-specific imaging prior to pre-operative chemotherapy for colorectal liver metastases reduces intra-hepatic recurrence and the need for a repeat hepatectomy.
Knowles B; Welsh FK; Chandrakumaran K; John TG; Rees M
HPB (Oxford); 2012 May; 14(5):298-309. PubMed ID: 22487067
[TBL] [Abstract][Full Text] [Related]
19. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial.
Nordlinger B; Sorbye H; Glimelius B; Poston GJ; Schlag PM; Rougier P; Bechstein WO; Primrose JN; Walpole ET; Finch-Jones M; Jaeck D; Mirza D; Parks RW; Mauer M; Tanis E; Van Cutsem E; Scheithauer W; Gruenberger T; ; ; ; ;
Lancet Oncol; 2013 Nov; 14(12):1208-15. PubMed ID: 24120480
[TBL] [Abstract][Full Text] [Related]
20. Radiofrequency Ablation to Improve Survival After Conversion Chemotherapy for Colorectal Liver Metastases.
Nielsen K; Scheffer HJ; Volders JH; van der Vorst MJ; van Tilborg AA; Comans EF; de Lange-de Klerk ES; Sietses C; Meijer S; Meijerink MR; van den Tol MP
World J Surg; 2016 Aug; 40(8):1951-8. PubMed ID: 27220509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
